Wang, Liping
First Affiliated Hospital of Zhengzhou University
5 papers on CoChatORCID 0000-0001-7107-1066
Most cited papers
- Verified
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research
Cancer Immunotherapy and BiomarkersImmune cells in cancer
Cited by 1,234
- Verified
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Zhou, C., Chen, G., Huang, Y., Zhou, J., Lin, L., Feng, J., Wang, Z., Shu, Y., Shi, J., Hu, Y., et al. (2021) · The Lancet Respiratory Medicine
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 483
- Verified
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
Li, J., Wang, L., Chen, X., Li, L., Li, Y., Ping, Y., Huang, L., Yue, D., Zhang, Z., Wang, F., et al. (2017) · OncoImmunology
Adenosine and Purinergic SignalingImmune cells in cancer
Cited by 299
- Verified
Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion
Wang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., Ping, Y., Shen, Z., Zheng, Y., Wang, L., et al. (2019) · Cancer Letters
Immune cells in cancerChemokine receptors and signaling
Cited by 183
- Verified
Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
He, J., Zhou, M., Chen, X., Yue, D., Yang, L., Qin, G., Zhang, Z., Gao, Q., Wang, D., Zhang, C., et al. (2016) · Journal of Experimental & Clinical Cancer Research
Cancer Cells and MetastasisEsophageal Cancer Research and Treatment
Cited by 85
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free